Qualigen Therapeutics Inc (QLGN)
0.301
+0.01
(+3.69%)
USD |
NASDAQ |
May 03, 16:00
0.3067
+0.01
(+1.89%)
After-Hours: 20:00
Qualigen Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.8739 |
| March 31, 2023 | 0.3116 |
| December 31, 2022 | 0.0083 |
| September 30, 2022 | 0.0775 |
| June 30, 2022 | 0.0649 |
| March 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.001 |
| September 30, 2020 | -0.3279 |
| June 30, 2020 | -0.1008 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.3279
Minimum
Sep 2020
0.8739
Maximum
Jun 2023
0.0757
Average
0.0005
Median
Debt to Equity Ratio Benchmarks
| Marizyme Inc | -0.9293 |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |
| IGC Pharma Inc | 0.0152 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.033M |
| Total Liabilities (Quarterly) | 4.137M |
| Shareholders Equity (Quarterly) | -2.104M |